Hematologic abnormalities in children and young adults receiving tacrolimus‐based immunosuppression following cardiothoracic transplantation
暂无分享,去创建一个
S. Webber | M. Michaels | J. Blatt | G. Boyle | Geoffrey Kurland | Nancy C. Dobrolet | Maria Kiaffas
[1] S. Nathan,et al. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] P. Suter,et al. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] R. Busuttil,et al. Red cell aplasia in children on tacrolimus after liver transplantation. , 1998, Transplantation.
[4] N. Embleton,et al. High prevalence of anemia after cardiac transplantation in children. , 1997, Transplantation.
[5] H. Antunes,et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. , 1997, Transplantation.
[6] R. Marugán,et al. Tacrolimus-induced bone marrow suppression , 1997, The Lancet.
[7] B. Griffith,et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. , 1997, The Journal of pediatrics.
[8] S. Webber,et al. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] S. Suzuki,et al. Pure red cell aplasia induced by FK506. , 1996, Transplantation.
[10] S. Boggs,et al. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD. , 1994, Bone marrow transplantation.
[11] T. Starzl,et al. Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. , 1991, Transplantation proceedings.